John Robertson

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 02, 2026
Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.

John F R Robertson, Teimuraz Gogitidze, Zaza Katashvili

|Jan 08, 2025
Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

John F R Robertson, Zhimin Shao, Shinzaburo Noguchi

|Mar 15, 2022
Transforming the 2-week wait (2WW) pathway: management of breast pain in primary care.

Mohamed Jahan, Thilan Bartholomeuz, Nikki Milburn

Pageof 1